Back to Polar Capital Holdings Plc Polar Capital Holdings Plc

CLDXCLDX
22 quarters

Position history for Polar Capital Holdings PlcPolar Capital Holdings Plc's holdings in Celldex Therapeutics, Inc.

Polar Capital Holdings Plc previously held 0 shares of CLDX (Celldex Therapeutics, Inc.), worth $0 as of 2026-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$17.5M

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$28.94
0
2025-Q4
Decreased
1M
-22.5%
$27.4M0.1%$26.43
0
2025-Q3
Increased
1.3M
+5.9%
$33.6M0.2%$26.19
37
2025-Q2
Decreased
1.2M
-12.5%
$25M0.1%$20.29
0
2025-Q1
Decreased
1.4M
-10.4%
$25.5M0.2%$19.93
0
2024-Q4
Decreased
1.6M
-42.5%
$39.6M0.2%$25.12
0
2024-Q3
Decreased
2.7M
-11.6%
$92.5M0.4%$33.20
0
2024-Q2
Increased
3.1M
+0.6%
$113.9M0.7%$37.01
42
2024-Q1
Decreased
3.1M
-2.4%
$128.4M0.7%$41.97
0
2023-Q4
Increased
3.1M
+29.2%
$124.4M0.8%$39.66
53
2023-Q3
Increased
2.4M
+0.4%
$66.8M0.5%$27.52
35
2023-Q2
Increased
2.4M
+6.6%
$82M0.4%$34.58
38
2023-Q1
Increased
2.3M
+46.3%
$81.6M0.5%$35.58
57
2022-Q4
Increased
1.6M
+7.0%
$69.1M0.6%$44.57
45
2022-Q3
Increased
1.4M
+123.8%
$40.7M0.3%$28.35
56
2022-Q2
Decreased
647,420
-48.2%
$17.5M0.1%$27.83
0
2022-Q1
Increased
1.3M
+25.0%
$42.6M0.2%$34.59
43
2021-Q4
Increased
1M
+38.3%
$38.6M0.1%$38.90
46
2021-Q3
Increased
722,843
+44.6%
$39M0.2%$51.97
47
2021-Q2
Unchanged
500,000
0.0%
$16.7M0.1%$35.37
0
2021-Q1
Decreased
500,000
-50.0%
$10.3M0.1%$19.73
0
2020-Q4
New
1M
-
$17.5M0.1%$17.88
47

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used